VanEck Associates
AHCO icon

VanEck Associates’s AdaptHealth AHCO Stock Holding History

VanEck Associates’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,262
Closed -$101K – 1397
2023
Q2 		$101K Buy
8,262
+110
+1% +$1.23K ﹤0.01% 1238
2023
Q1 		$126K Sell
8,152
-5,170
-39% -$95.1K ﹤0.01% 1219
2022
Q4 		$256K Buy
13,322
+2,683
+25% +$56.7K ﹤0.01% 1038
2022
Q3 		$200K Buy
+10,639
New +$219K ﹤0.01% 1027

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

VanEck Associates's AHCO Position: Q3 2023 in Review

VanEck Associates sold out of AdaptHealth (AHCO) in Q3 2023, closing a stake of 8,262 shares — an estimated $101K sold.

VanEck Associates first reported a position in AHCO in Q3 2022 and held it in 4 quarters. The position peaked at $256K in Q4 2022. 191 funds tracked by Wall St. Rank hold AHCO as of Q3 2023.

  • VanEck Associates reported no remaining AdaptHealth position as of Q3 2023 after selling out during the quarter.
  • VanEck Associates sold 8,262 AdaptHealth shares in Q3 2023, an estimated $101K.
  • VanEck Associates first reported a position in AdaptHealth in Q3 2022 and held it in 4 quarters.
  • VanEck Associates's AdaptHealth position peaked at $256K in Q4 2022.
  • 191 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2023.

Based on VanEck Associates's 13F filing for Q3 2023, filed 8 Nov 2023.